Otolaryngology

24-week randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of intranasal administration of 186 and 372 μg of OPN-375 BID in subjects with chronic sinusitis, without nasal polyps

A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of Clotrimazole 1/% Otic Solution Compared to Placebo for the Treatment of Fungal OPtitis Externa (Otomycosis)